Dr. Renata Ferrarotto
Claim this profileM D Anderson Cancer Center
Studies Squamous Cell Carcinoma
Studies Adenoid Cystic Carcinoma
13 reported clinical trials
21 drugs studied
Area of expertise
1Squamous Cell Carcinoma
Stage IV
HPV16 positive
Stage II
2Adenoid Cystic Carcinoma
Stage IV
Stage III
NOTCH1 positive
Affiliated Hospitals
Clinical Trials Renata Ferrarotto is currently running
Sacituzumab Govitecan
for Salivary Gland Cancer
To learn if sacituzumab govitecan can help to control salivary gland cancer.
Recruiting1 award Phase 2
REM-422
for Advanced Cancer
This trial is testing REM-422, an oral medicine, in people with advanced Adenoid Cystic Carcinoma (ACC) that has returned or spread. REM-422 aims to reduce a protein needed for cancer growth by breaking down its mRNA. The study will determine the best dose and evaluate its safety and effectiveness.
Recruiting1 award Phase 116 criteria
More about Renata Ferrarotto
Clinical Trial Related4 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Renata Ferrarotto has experience with
- Docetaxel
- Pembrolizumab
- Cemiplimab
- Cisplatin
- ISA101b
- Sacituzumab Govitecan
Breakdown of trials Renata Ferrarotto has run
Squamous Cell Carcinoma
Adenoid Cystic Carcinoma
Cancer
Salivary Gland Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Renata Ferrarotto specialize in?
Renata Ferrarotto focuses on Squamous Cell Carcinoma and Adenoid Cystic Carcinoma. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are HPV16 positive.
Is Renata Ferrarotto currently recruiting for clinical trials?
Yes, Renata Ferrarotto is currently recruiting for 3 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Renata Ferrarotto has studied deeply?
Yes, Renata Ferrarotto has studied treatments such as Docetaxel, Pembrolizumab, Cemiplimab.
What is the best way to schedule an appointment with Renata Ferrarotto?
Apply for one of the trials that Renata Ferrarotto is conducting.
What is the office address of Renata Ferrarotto?
The office of Renata Ferrarotto is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.